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Approximately 30,000 people per annum undergo major, emergency abdominal, gastrointestinal surgery, of            
which 36% (~10,800) are carried out for emergency colorectal pathology. Approximately 14% of all patients               
requiring emergency surgery undergo laparoscopic surgery.  
 
Aims 
The aims of the LaCeS feasibility trial (Laparoscopic versus Open Colorectal Surgery in the Acute Setting) were                 
to assess the feasibility, safety and acceptability of performing a large-scale definitive phase III randomised               





LaCeS was designed as a prospective, multicentre, single blind, parallel group, pragmatic, randomised             
controlled feasibility trial with an integrated qualitative study. Randomisation was performed centrally with             
patients being randomised on a 1:1 basis between laparoscopic or open surgery.  
 
Results 
A total of 64 patients were recruited across 5 centres. The overall average steady state recruitment rate was 1.2                   
patients/month. Baseline compliance for clinical and HrQoL data was 99.8% and 93.8% respectively. The              
conversion rate from laparoscopic to open surgery was 39.4% (95% CI 22.9% – 57.9%). The 30 day                 
post-operative complication rate was 27.3% (95% CI 13.3- 45.5) in the laparoscopic arm and 41.9% (95% CI                 
24.6 – 60.9) in the open arm.  
 
Discussion 
The LaCeS feasibility trial has demonstrated that it is possible to evaluate laparoscopic surgery in the                
emergency colorectal setting within the context of a randomised controlled trial. LaCeS has demonstrated that it                
is possible to recruit to a surgical trial in the emergency setting, with good compliance to trial procedures and                   
processes, and overall acceptability by patients and clinicians. The safety data obtained for laparoscopic              
emergency colorectal surgery indicate an acceptable safety profile, particularly when considering it to that              
observed in the open arm. 
 
Trial Registration ISRCTN15681041 ​ ​https://doi.org/10.1186/ISRCTN15681041​. 
Funding body: National Institute of Health Research – Research for Patient Benefit 
 
Background 
The National Emergency Laparotomy Audit (NELA) reports approximately 30,000 people per annum undergo             
major, abdominal, gastrointestinal surgery, of which 36% (~10,800) are carried out for emergency colorectal              
pathology (1). ​The management of emergency colorectal pathology can be challenging due to the range of                
presenting pathology, including colorectal cancer, inflammatory bowel disease and diverticular disease,           
combined with variable patient physiology, associated sepsis and potentially advanced disease. Emergency            
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colorectal surgery is associated with significant morbidity, with ​reported rates of post-operative morbidity and              
mortality of ​33-71%​ and ​14-17%,​ respectively (2, 3).  
 
A number of initiatives have launched over the last decade to improve outcomes in patients undergoing                
emergency laparotomy, including the use of peri-operative bundles to identify high-risk patients (4, 5), timely               
management of sepsis and delivery of consultant-led services. Surgeons have started to explore the possibility of                
adopting a laparoscopic approach in the emergency setting (6). The hypothesis being that the reduced               
physiological insult associated with laparoscopic surgery will have similar benefits in the emergency setting as               
that previously seen in the elective setting, leading to reduced pain, earlier recovery and shorter length of                 
hospital stay. The current evidence base informing the use of laparoscopic surgery in the emergency colorectal                
setting is weak, being limited to a small number of population-based registries and retrospective cohort studies                
(7-9). Although initial reports indicate benefits of laparoscopic surgery in the emergency colorectal setting, the               
findings are not uniform across a highly selected patient population consisting of younger and physiologically               
fitter patients (7). There is a lack of transparent outcome reporting with missing data on complications,                
re-operation rates and mortality. In a systematic review of 39 studies, Agresta et al concluded that the current                  
evidence for emergency laparoscopic colorectal surgery was ‘early, controversial and focused on short term              
outcomes’(9). The lack of confirmatory data regarding the benefits of emergency laparoscopic colorectal             
surgery has in part led to the lack of adoption in clinical practice, with NELA reporting static rates of emergency                    
laparoscopic surgery of ~14% over the last 3 years (1).   
 
Surgical trials are associated with a number of practical and methodological challenges, which include              
difficulties in randomisation, lack of equipoise ​(10) and variability in experience and delivery of surgical               
interventions. ​Surgical trials in the emergency setting add an additional layer of complexity given the time                
constraints associated with delivering definitive treatment and balancing this against trial-related processes            
including consent and recruitment. A number of surgical trials have closed early in the emergency colorectal                
setting due to either poor recruitment rates (11) (12) or a higher than anticipated rate of adverse events (13).                   
Given these recognised difficulties, a feasibility trial investigating emergency laparoscopic colorectal surgery            
was conducted​. The aims of the LaCeS feasibility trial (Laparoscopic versus Open Colorectal Surgery in the                
Acute Setting) were to assess the feasibility, safety and acceptability of performing a large-scale definitive phase                
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III randomised controlled trial with a comparison of emergency laparoscopic with open surgery for acute               




LaCeS was designed as a prospective, multicentre, single blind, parallel group, pragmatic, randomised             
controlled feasibility trial with an integrated qualitative study. The LaCeS feasibility trial protocol has been               
published previously (14). The LaCeS feasibility trial is approved by the Yorkshire and The Humber Research                
Ethics Committee (REC reference: 15/YH/0542). 
 
Patients were recruited from five NHS trusts across the UK. All participating sites had dedicated emergency                
surgery services with appropriate provisions and expertise to conduct laparoscopic surgery. Randomisation was             
performed centrally with patients being randomised on a 1:1 basis between laparoscopic or open surgery using                
minimisation incorporating a random element, stratified by intended consultant surgeon, patient age, body mass              
index (BMI), ​American Society of Anesthesiologists (ASA) status, nature of underlying pathology and intended             
surgical procedure. Patients were blinded to treatment allocation for up to 7 days post-operatively, ​or until the                 
day of discharge if earlier. 
 
Eligibility  
Patient inclusion criteria included: age ≥18 years old, acute colorectal pathology requiring resectional surgery, a               
National Confidential Enquiry into Patient Outcome and Death (NCEPOD) classification of urgent requiring             
surgery between 2-6 hours (Classification 2A) or 6-18 hours (Classification 2B), suitability for both              
laparoscopic and open surgery, and ability to either provide written informed consent or use of a personal                 
consultee to provide advice on participation in the case of temporary impairment in capacity. Patient exclusion                
criteria included: haemodynamic instability requiring inotropic support, acute non-colorectal pathology,          
hand-assisted laparoscopic surgery, laparoscopy and peritoneal lavage alone for colorectal pathology, insertion            
of an endoscopic stent as a bridge to surgery, pregnancy, pre-existing cognitive impairment, and participation in                
another surgical trial. Surgeon eligibility criteria included: a minimum of 50 previously performed laparoscopic              
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colorectal resections, with an annual rate of at least 20 elective laparoscopic resections, with equivalent               
experience in the open setting.  
 
Treatment  
Peri-operative treatment of patients was as per institutional protocol. Laparoscopic surgery included the use of               
multi-port and single-port incisions to establish pneumoperitoneum and facilitate surgical resection. Conversion            
to open was defined as the use of a midline laparotomy wound for any part of the colorectal dissection. The use                     
of a midline wound to facilitate specimen extraction was permissible. Open surgery was performed through a                
standard midline laparotomy.  
 
Outcome Assessment  
A mixed-methods approach was employed to assess recruitment, feasibility and acceptability of the trial, and               
also the safety profile of laparoscopic surgery in the acute setting as described:  
 
● Recruitment  
The primary outcome measure of the LaCeS trial was the overall recruitment rate, with an anticipated                
recruitment rate of one patient per centre per month. Total numbers of screened, eligible and randomised                
patients were examined to identify the total available population pool for inclusion into a future phase III trial.                  
Qualitative data were gathered to assess both the practicalities of recruitment and randomisation in the               
emergency setting.  
 
● Feasibility and acceptability of trial processes  
The feasibility of data collection was examined, including the collection of patient and disease characteristics,               
operative data, pain, health-related quality of life (HrQoL), health care resource use, post-operative morbidity              
and mortality data, re-operation and re-admission data. Patient-reported generic HrQoL was measured using the              
SF-12​® ​questionnaire (15) and EQ-5D-5L™(16), whilst disease specific HrQoL was measured using the             
Gastrointestinal Quality of Life Index (GIQLI) (17). Patient-reported pain was measured using an adapted              
version of the Brief Pain Inventory (BPI) (18). Health care resource use was captured using clinician completed                 
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procedure and discharge forms, which captured procedure staffing, assessments conducted, imaging,           
medications and length of stay. Patient completed forms captured use of primary and secondary care. Data were                 
collected on paper by clinicians, trainees and research nurses and uploaded centrally to the clinical trials unit                 
(CTRU).  
 
The feasibility of longitudinal clinical and patient-reported data collection were assessed at baseline, 7 days, 30                
days, 3, 6 and 12 months (the latter using a subset of patients) post-operatively. Patient questionnaires were                 
completed in hospital; baseline questionnaires were completed prior to randomisation. Data compliance was             
calculated for each of these time points as the proportion of completed case report forms (CRFs) or HrQoL                  
questionnaires returned to the CTRU.  
 
The Bang Blinding Index was used to assess the success of blinding (19). When calculated the index takes                  
values between -1 to 1; 1 indicates a complete lack of blinding, 0 is consistent with perfect blinding and -1                    
indicates opposite guessing which may be related to unblinding.  
 
The acceptability of trial processes and follow up were assessed using in-depth qualitative interviews with               
clinicians and patients(14). All interviews were informed by a topic guide and were audio-recorded and               
transcribed verbatim. Qualitative data were analysed using the principles of thematic analysis (20) in NVivo               
(21). Data were coded independently by two qualitative researchers for emerging themes. Codes and themes               
were compared and contrasted between the two researchers and any discrepancies were resolved by consensus. 
  
● Safety  
The safety of laparoscopic emergency colorectal surgery was assessed by measuring intra-operative and             
post-operative complication and mortality rates. Patient safety indicators (PSI) as defined by the Agency for               
Healthcare Research and Quality were also collected. PSIs are a measure of adverse events that patients                






Endpoint evaluation was carried out to establish optimal outcome measures and their timings to inform the                
design of a large-scale, definitive trial. Qualitative interviews explored a range of clinical and patient-reported               
outcomes to identify which endpoint will be of most meaning and value to clinicians and patients as a primary                   
endpoint for a definitive trial. Candidate endpoints were analysed quantitatively for completion rates and              
estimation of variability to help inform future power calculations.  
 
Sample size 
The target sample size of at least 66 participants was determined to allow precise estimation of parameters of                  
interest according to published recommendations (22) and accounting for a 10% attrition rate. In addition, this                
sample size allows the estimation of morbidity and mortality rates in the laparoscopic arm with 95% 2-sided                 
confidence intervals (CI) of at most ±17%, allowing its safety profile to be demonstrated. Achieving this                
recruitment target from five centres over a 15 month period also allows pragmatic estimation of the recruitment                 
rate for a definitive, phase III trial, as well as demonstrating feasibility. 
 
Statistical Analysis  
No endpoints were subjected to formal statistical testing as no statistical hypotheses were proposed or powered.                
Data were summarised descriptively using appropriate frequencies and summary statistics, estimating levels of             
variability using SAS version 9.4 ​(SAS Institute Inc., Cary, NC, USA)​. Data summaries included all randomised                
patients according to the intervention received. 
 
Results 
Recruitment and Patient Characteristics 
Patients were recruited from two teaching hospitals and three district general hospitals across the UK; with four                 
sites providing emergency general surgery services and one site providing a dedicated colorectal emergency              
surgery service. Thirteen surgeons recruited patients across all sites between July 2016 and November 2017.               
According to the NELA dataset, 564 patients were identified as undergoing emergency colorectal resection              
across the five trial sites during the recruitment period. A total of 119 patients were screened and were assessed                   
for eligibility, of which 94 (79.0%) patients were considered eligible and 72 (76.6% of 94 considered eligible)                 
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patients were approached to participate in the trial. A total of 64 (53.8% of 119 screened; 88.9% of 72                   
approached) patients were randomised; 33 to laparoscopic surgery and 31 to open surgery (Figure 1). All                
patients received their allocated treatment arm. Twenty-five patients were ineligible for inclusion into the trial               
(Figure 1). Eight patients declined participation in the trial (Figure 1). Twenty-two screened patients were not                
approached by the research teams; the most common reason for this was the lack of a randomising consultant on                   
call.  
 
The overall average steady state recruitment rate was 1.2 patients/month per site. The steady state recruitment                
rate per site varied between 0.57 – 2.78 patients per month (Figure 2). The overall average steady state                  
recruitment rate was 0.9 patients/month per site when the lead site assumed the rate of the next highest                  
recruiting site.  
 
The baseline characteristics of all randomised patients are tabulated (Table 1). The recruited patient population               
demonstrates good representation of ages, physiological status and disease types.  
 
Qualitative interviews were conducted with 16 trial patients - six received laparoscopic surgery, three had               
laparoscopic converted to open surgery and seven received open surgery – and 14 healthcare professionals -                
eight consultant surgeons, three research nurses and three surgical trainees. Qualitative data identified that the               
recruitment and randomisation processes were acceptable. Patients were accepting of the trial design and the               
treatment arms and were willing to be appropriately recruited and randomised. A small proportion of patients                
did express a treatment preference however, this was not considered to be a barrier to participating in the trial.                   
Barriers to recruitment from a clinical perspective included: lack of complete equipoise, with this being most                
relevant in younger patients and patients with inflammatory bowel disease; difficulty in addressing and              
challenging patient treatment preferences; and reluctance to approach acutely unwell patients or patients with a               
complex clinical diagnosis. Organisational barriers to recruitment were identified as lack of available colorectal              
surgeons on-call, lack of research nurse support and lack of previous experience in recruiting into trials.  
 
Feasibility and acceptability of trial processes  
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● Data compliance 
Overall, compliance with collection of clinical and patient-reported HrQoL data at baseline and follow-up was               
good (Table 2). Baseline compliance for clinical and HrQoL data was 99.8% and 93.8% respectively. Data                
compliance related to important clinical endpoints including conversion rates, re-operation rates, re-admission            
rates, patient safety indicators, length of stay, post-operative morbidity and mortality rates, and restoration of               
gastrointestinal function were all above 95%. Compliance rates for clinical data remained above 90%              
throughout the follow-up period (Table 2). Compliance rates for the patient-reported HrQoL questionnaires             
declined during the trial follow-up period to 58.3% at 12 months (Table 2 & Appendix A). Health care resource                   
use data provided by health care professionals was of a high quality and in most cases achieved 100%                  
completion. Patient completed resource use form returns declined over time but were at least 50% at 6 months                  
(Appendix B).  
 
● Blinding 
A total of eight patients were unblinded during the trial; one patient was unblinded by the anaesthetic team                  
pre-operatively, two patients were informed of their treatment allocation post-operatively, three patients were             
unblinded during dressing changes and two patients were unblinded prior to filling out the Bang Blinding Index.                 
The Bang Blinding Index was 0.21 (95% CI 0.14 – 0.27) in the laparoscopic arm and 0.53 (95% CI 0.48 – 0.59)                      
in the open arm. These results suggest there was a failure to adequately blind patients in both treatments arms.  
 
● Acceptability of trial processes 
Qualitative interviews conducted with patients identified the trial processes to be acceptable; however, patients              
felt that the number of questionnaires required to be completed was high. Patients felt the pain questionnaire                 
(Brief Pain Inventory) was irrelevant and not an appropriate assessment measure in the emergency setting.               
Patients expressed that they would have liked online and paper access to questionnaires. Patients found the                
process of blinding unnecessary and often, correctly, guessed their treatment allocation. Patients expressed a              
preference to be told of their treatment allocation immediately post-operatively, as opposed to being blinded for                




Overall, healthcare professionals were accepting of the trial design and trial-related processes. Despite             
appropriate measures being in place to maintain blinding, including appropriate ward notes, team briefings              
across all medical and nursing staff and appropriate signage and documentation, surgeons felt that blinding was                
impractical in the emergency setting. The follow-up processes were deemed to be challenging by the research                
nurses, as the time points did not always coincide with a natural clinical visit. However, surgeons regarded the                  
time points as important and agreed that the proposed time points were appropriate to ensure all relevant                 
differences between the two treatment arms were appropriately captured. Surgeons agreed that a minimum              
follow-up period of 12 months was necessary to appropriately evaluate the short- and medium-term outcomes of                
emergency laparoscopic colorectal surgery.  
 
Safety 
Overall, the safety data obtained for laparoscopic emergency colorectal surgery indicate an acceptable safety              
profile. A total of 22 patients experienced a post-operative complication within 30 days; this extended to 25                 
patients within 90 days (Table 3). There were a total of four deaths during the trial period; one death was within                     
90 days of surgery.  
 
The conversion rate from laparoscopic to open surgery was 39.4% (95% CI 22.9% – 57.9%), with 13 patients                  
being converted. The decision made to convert was on establishment of pneumoperitoneum in 1 patient,               
following a period of trial dissection in 11 patients and due to an intra-operative complication in 1 patient. 
 
 
Endpoint Evaluation  
Qualitative interviews with patients identified post-operative complications as an important outcome when            
undergoing emergency surgery. Other important outcomes to patients were HrQoL and post-operative recovery.             
Surgeons participating in the LaCeS feasibility trial shared this perspective, and considered a reduction in               
post-operative complications to be an important key outcome in the evaluation of laparoscopic emergency              





The LaCeS feasibility trial has demonstrated that it is possible to evaluate laparoscopic surgery and open                
surgery in the emergency colorectal setting within the context of a randomised controlled trial. LaCeS               
demonstrates that it is possible to recruit to a surgical trial in the emergency setting, with good compliance to                   
trial procedures and processes, and overall acceptability by patients and clinicians. Our safety data suggests that                
emergency colorectal laparoscopic surgery has an acceptable safety profile. The observed conversion rate is              
slightly lower than current clinical practice, with NELA reporting a 47% conversion rate (1), and the observed                 
morbidity rate is similar to current published evidence. 
 
The LaCeS trial is relevant to a significant proportion of patients undergoing emergency surgery, with the                
NELA dataset identifying a patient population pool of 564 patients who underwent emergency colorectal              
surgery across the five participating centres during the recruitment. Our screening method captured 119 (21.1%)               
patients throughout this time period, of which the majority of patients (n=94, 79.0%) were eligible for                
participation into the trial. This reflects the pragmatic nature of our trial, with our eligibility criteria                
appropriately reflecting current clinical practice. Our steady state rates of recruitment across participating sites              
reflect that it is feasible to recruit across a range of hospital types and emergency surgery services, including                  
split subspecialty (upper and lower gastrointestinal surgery) and general surgery on-call rotas. The ability to               
recruit across a range of hospitals is important to ensure appropriate upscaling to a definitive phase III trial                  
within the NHS, to ensure the generalisability of future results and to enable widespread future implementation                
of emergency laparoscopic surgery.  
 
Challenges to recruitment in surgical trials are well recognised and include lack of equipoise, the complexity of                 
combining clinical and research activities, lack of training and inability to explore patient treatment preferences               
(23-25). There is a paucity of well-conducted research into recruitment strategies in the emergency setting (26).                
Our feasibility work identifies the challenges of recruiting in the emergency setting with difficulties encountered               
in approaching and recruiting clinically complex patients, challenging patient and surgeon equipoise combined             
with the time constraints of initiating and delivering definitive treatment. Surgeons participating in our              
integrated qualitative study felt some of these barriers to recruitment can be overcome with appropriate               
trial-specific training. The use of qualitative methods to explore recruitment within elective clinical trials are               
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well documented and have been shown to be effective in identifying challenges in recruitment, proposing               
appropriate strategies to overcome these challenges and driving training pathways (27, 28). Qualitative             
initiatives such as ​QuinteT (qualitative research integrated in ​trials​) (29) ​and Granule (generating recruiters for             
randomised trials in surgery) have revolutionised the manner in which surgeons and surgical trainees are trained                
to approach, recruit and randomise patients. It is clear these are required to explore and maximise recruitment                 
within the emergency setting. We will continue to build on the qualitative work undertaken in the LaCeS                 
feasibility trial to refine our trial design for phase III and to continue exploring recruitment strategies in the                  
emergency setting and developing trial-specific training packages.  
 
Our high rates of baseline compliance for clinical data (99.8%) and for patient-reported HrQoL data (93.8%)                
demonstrate that it is possible to collect trial related data from an acutely unwell population. The routine                 
collection of patient-reported outcome data in the emergency setting has been previously documented to be of                
low quality, with poor reporting of baseline data (30). This is coupled with high rates of attrition, with Mason et                    
al reporting 6 week response rates of 48.4% despite an initial baseline compliance rate of 93% amongst 156                  
patients presenting to emergency general surgery services (31). LaCeS demonstrates that it is possible to collect                
high volume, good quality clinical and patient-reported outcome data in the emergency setting both at baseline                
and during follow up. Although we did observe attrition during the follow-up period with regards to HrQoL                 
data, our response rates were much higher than previously reported at all candidate follow up time points (31),                  
with our lowest response rate of 58.3% observed at 12 months. Data from qualitative interviews with patients                 
suggested that the burden of questionnaire completion was high, and there were some questionnaires that were                
deemed to be irrelevant to their clinical status. It is possible that as patients improved clinically and recovered                  
from surgery, they were less inclined to complete HrQoL questionnaires due to the lack of relevance. The mode                  
of our follow up visits also changed as the trial progressed, with a greater proportion of the later follow up visits                     
being undertaken over the telephone. Research nurses stated this made it more difficult to complete and collect                 
HrQoL data, which may have contributed to our reduced response rates at 6 and 12 months post-operatively.                 
The collection of HrQoL data in the emergency setting therefore requires the use of appropriate, accessible and                 
user-friendly patient reported outcome measures, coupled with a follow up strategy that is relevant and               
acceptable to patients and clinicians. It is clear from our feasibility trial that the majority of our proposed                  




Feasibility trials are important in providing sufficient methodological evidence regarding trial design, delivery             
and justification. The successful delivery of the LaCeS feasibility trial has identified that we are able to recruit                  
in the emergency setting and initiate trial-related processes whilst delivering definitive emergency care in a               
timely manner. This trial has enabled us to pilot our data collection, blinding and follow up processes, and                  
appropriately assess their efficacy. Employing this approach prior to conducting a large-scale, definitive trial              
ensures the feasibility of delivery of the definitive trial, the acceptability and appropriate modification of the                
proposed trial processes. To evaluate the role, efficacy and safety of laparoscopic surgery in the emergency                
colorectal setting, a further large scale, definitive, phase III, multi-centre, randomised controlled trial is required.               
The data from the LaCeS feasibility trial demonstrates it is feasible to deliver such a trial comparing                 
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